Ciprofloxacin hydrochloride monohydrate
Cat. No.：YN251019
| 产品名称: | Ciprofloxacin hydrochloride monohydrate |
| CAS No.: | 86393-32-0 |
| Chemical Name: | 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid, monohydrochloride, monohydrate |
| Synonyms: | 环丙沙星盐酸盐一水合物; Bay-09867 hydrochloride monohydrate |
| 分子量: | 385.82 |
| 分子式: | C₁₇H₂₁ClFN₃O₄ |
| SMILES: | [H]O[H].[H]Cl.O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4CCNCC4)=C3)C1=O)O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Ciprofloxacin hydrochloride 是一种氟喹诺酮类抗生素，具有高效的抗菌活性。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Drlica, K., and Zhao, X.DNA gyrase, topoisomerase IV, and the 4-quinolonesMicrobiol. Mol. Biol. Rev.61(3),377-392(1997)
Nilius, A.M., Shen, L.L., Hensey-Rudloff, D., et al.In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinoloneAntimicrob. Agents Chemother.47(10),3260-3269(2003)
Bansal, M.B., and Thadepalli, H.Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitroAntimicrob. Agents Chemother.31(4),619-621(1987)
Takei, M., Fukuda, H., Kishii, R., et al.Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibitionAntimicrob. Agents Chemother.45(12),3544-3547(2001)
Easmon, C.S.F., Crane, J.P., and Blowers, A.Effect of ciprofloxacin on intracellular organisms: In-vitro and in-vivo studiesJ. Antimicrob. Chemother.18 (Suppl D),43-48(1986)
Zeiler, H.J., and Grohe, K.The in vitro and in vivo activity of ciprofloxacinEur. J. Clin. Microbiol.3(4),339-343(1984)
